NOD2 and colorectal carcinoma: Interestingly, Freire et al. found a significantly higher incidence of NOD2 mutations in patients with CRC diagnosed under 60 years of age (28.6% vs. 10.4%, p = 0.015) and in female patients (24.4% vs. 10.4%, p = 0.048) [52].